Journal article

Switch from Type II to I Fas/CD95 Death Signaling on In Vitro Culturing of Primary Hepatocytes

Dorothee Walter, Kathrin Schmich, Sandra Vogel, Robert Pick, Thomas Kaufmann, Florian Christoph Hochmuth, Angelika Haber, Karin Neubert, Sabine McNelly, Fritz von Weizsaecker, Irtugard Merfort, Ulrich MaUrer, Andreas Strasser, Christoph Borner

Hepatology | WILEY | Published : 2008

University of Melbourne Researchers

Grants

Awarded by Spemann Graduate School of Biology and Medicine of the Deutsche forschungsgemeinschaft


Awarded by Australian National Health and Medical Research Council (Canberra)


Awarded by National Cancer Institute


Awarded by Leukemia and Lymphoma Society of America


Awarded by NATIONAL CANCER INSTITUTE


Funding Acknowledgements

This work was supported by the Hepatosys program of the Bundesministerium fur Bildung and forschung (to C.B., D.W., R.P., K.S., I.M., and F.vW) and the Spemann Graduate School of Biology and Medicine of the Deutsche forschungsgemeinschaft (GSC-4) (to C.B and S.V.). A.S. and T.K. were supported by grants (program 257502) and fellowships from the Australian National Health and Medical Research Council (Canberra), the National Cancer Institute (U.S. National institute of Health; CA80188, CA 43540), the Leukemia and Lymphoma Society of America (SCOR grant 7015), the Juvenile Diabetes Research Foundation/NHMRC, the Swiss National Science Foundation, the Roche Research Foundation, and the Novartis Foundations (to T.K)